InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,189.60
(
0.08%
)
Dow Jones
39,112.16
(
0.00%
)
Brent Oil
84.67
(
0.57%
)
Bitcoin
61,447.05
(
-0.59%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

joecarry

Send PM Follow Ignore
Followers 0
Posts 94
Boards Moderated 0
Alias Born 07/02/2015

joecarry

Re: elysse1kittycat post# 89813

Tuesday, 11/10/2015 9:58:49 AM

Tuesday, November 10, 2015 9:58:49 AM

Post# of 92948
If Astellas Pharmaceutical successfully acquires OCATA they would own all of OCATA's technology, patents, intellectual property, etc.

So, wouldn't taking your $8.50 per share after the acquisition and buying Astellas stock be prudent if OCATA really has a valid treatment that shows improvement for AMD/SMD?

Or am I missing something here?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up